1992
DOI: 10.1016/s0022-3476(05)81809-8
|View full text |Cite
|
Sign up to set email alerts
|

Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0
1

Year Published

1995
1995
2013
2013

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(11 citation statements)
references
References 13 publications
0
10
0
1
Order By: Relevance
“…24 " 28 . Other agents, such as growth hormone, calcitonin, sodium fluoride and anabolic steroids, have not been shown to be associated with significant or sustained improvement in bone quality 15,29 . The primary objective of this study was to assess the effect of bisphosphonate treatment in children with milder forms of 01, in whom it is not routinely used.…”
Section: Introductionmentioning
confidence: 99%
“…24 " 28 . Other agents, such as growth hormone, calcitonin, sodium fluoride and anabolic steroids, have not been shown to be associated with significant or sustained improvement in bone quality 15,29 . The primary objective of this study was to assess the effect of bisphosphonate treatment in children with milder forms of 01, in whom it is not routinely used.…”
Section: Introductionmentioning
confidence: 99%
“…Accordingly, in 48 children with osteogenesis imperfecta treated with salmon calcitonin (2 IU/kg three times a week) for up to 48 weeks a reduction in annualized fracture rates relative to the pretreatment period was observed [110]. A decrease in fracture rate has also been reported in a Japanese series of patients with osteogenesis imperfecta treated sequentially with injectable and intermittent intranasal calcitonin regimens for 22-68 months [111]. The availability of other therapeutic options has reduced the interest for calcitonin in osteogenesis imperfecta, and no further studies have been conducted in the last decade.…”
Section: Calcitonin In Other Pathologic Conditionsmentioning
confidence: 87%
“…Currently, treatments for BMD deficits among childhood cancer survivors include dietary counseling and supplementation to ensure adequate calcium and vitamin D intake [85]. Vitamin D and calcium supplementation has demonstrated efficacy in children with decrements in BMD following diagnosis of juvenile rheumatoid arthritis [86], idiopathic juvenile osteoporosis [87] and osteogenesis imperfect [88]. Early identification and treatment of conditions that may exacerbate or accelerate bone loss, such as hypogonadism and GH deficiency, are also important in children or adolescents being treated for cancer [85].…”
Section: Prevention and Treatmentmentioning
confidence: 99%